Get the Stockscreener App
36.70
1.50%
-0.56
Bruker Corp stock is traded at $36.70, with a volume of 1.47M.
It is down -1.50% in the last 24 hours and down -7.88% over the past month.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
See More
Previous Close:
$37.26
Open:
$36.69
24h Volume:
1.47M
Relative Volume:
0.62
Market Cap:
$5.56B
Revenue:
$3.24B
Net Income/Loss:
$304.90M
P/E Ratio:
17.64
EPS:
2.08
Net Cash Flow:
$156.70M
1W Performance:
+3.38%
1M Performance:
-7.88%
6M Performance:
-36.67%
1Y Performance:
-44.00%
1-Day Range:
$36.01
$37.27
1-Week Range:
$36.01
$37.97
52-Week Range:
$34.10
$72.94
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978663-3660
Address
40 MANNING RD, BILLERICA, MA
Compare BRKR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
36.70 | 5.38B | 3.24B | 304.90M | 156.70M | 2.08 |
|
ABT
Abbott Laboratories
|
133.58 | 228.44B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
105.26 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
382.64 | 143.93B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
82.98 | 103.43B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.22 | 43.99B | 5.54B | 4.18B | 623.10M | 7.00 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-10-24 | Initiated | UBS | Neutral |
| Dec-05-24 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-24 | Initiated | Barclays | Overweight |
| Sep-30-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-21-22 | Initiated | UBS | Buy |
| Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
| Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-02-20 | Initiated | Goldman | Sell |
| Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-24-19 | Reiterated | Needham | Strong Buy |
| Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| May-06-19 | Reiterated | Needham | Strong Buy |
| May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-03-19 | Upgrade | UBS | Sell → Neutral |
| Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-12-19 | Reiterated | BTIG Research | Buy |
| Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
Bruker Corporation to Present at the Jefferies Global Healthcare Conference - Yahoo
Bruker (BRKR) Introduces Advanced Mass Spectrometry System | BRK - GuruFocus
Bruker launches timsOmni system for advanced proteomics - Investing.com
Bruker Launches Revolutionary timsOmniTM Mass Spectrometer – Company Announcement - Financial Times
Bruker (BRKR) Unveils Advanced 4D-Metabolomics System | BRKR Stock News - GuruFocus
Bruker unveils new timsMetabo system for metabolomics - Investing.com
Bruker Launches Novel timsMetabo™ Mass Spectrometer for Breakthrough 4D-Metabolomics and 4D-Lipidomics Sensitivity, Specificity and Annotation Confidenceat Speed, Depth, and Scale – Company AnnouncementFT.com - Financial Times
Bruker Stock to Gain From the Launch of MOVE-T Liquid Dairy Analyzer - Yahoo Finance
Bruker launches MOVE-T for dairy quality control By Investing.com - Investing.com South Africa
Bruker Corp: Pan-Omics Dominance At A Margin Inflection Point (BRKR) - Seeking Alpha
Bruker launches MOVE-T for dairy quality control - Investing.com
Bruker Introduces Novel MOVE-T System for Transferable, Robust Milk and Liquid Dairy Analysis with FT-NIR Technology - Quantisnow
Bruker Corp (BRKR) Shares Up 4.51% on May 27 - GuruFocus
Bruker (BRKR) Downgraded by Citigroup with Price Target Lowered to $40 | BRKR Stock News - GuruFocus
Expert Outlook: Bruker Through The Eyes Of 8 Analysts - Benzinga
This Guidewire Software Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
Citi cuts Bruker stock rating, lowers price target to $40 - Investing.com
Bruker (BRKR) Downgraded to Neutral by Citi with $40 Price Target | BRKR Stock News - GuruFocus
Bruker Corp (BRKR) Shares Down 3.3% on May 21 - GuruFocus
Benchtop Optofluidic System | Bruker Nano Surfaces | Products - Photonics Spectra
Bruker (BRKR) Shows Positive Signals Post-Settlement | BRKR Stock News - GuruFocus
July 18th Options Now Available For Bruker (BRKR) - Nasdaq
Bruker (BRKR) and 10x Genomics Resolve Global Patent Dispute | B - GuruFocus
Bruker (BRKR) and 10x Genomics Settle Patent Disputes Globally - GuruFocus
Bruker Sets Next Dividend Payment: $0.05 Per Share Coming June 27Key Dates Inside - Stock Titan
10x Genomics settles patent dispute with Bruker for $68 million By Investing.com - Investing.com Canada
10x Genomics settles patent dispute with Bruker for $68 million - Investing.com
10x Genomics Announces Patent Litigation Settlement Agreement with Bruker - Financial Times
Bruker and 10x Genomics settle patent dispute - Yahoo Finance
Two Photon Microscope | Bruker Nano Surfaces | Products - Photonics Spectra
Bruker (BRKR) and 10x Genomics Settle Patent Dispute with Cross-License Agreement | BRKR Stock News - GuruFocus
Investors Can Find Comfort In Bruker's (NASDAQ:BRKR) Earnings Quality - Yahoo Finance
Major Patent Battle Ends: Bruker and 10x Genomics Strike Global Deal to Protect Spatial Biology Innovation - Stock Titan
10x Genomics, Bruker Strike Deal After $31M Patent Verdict - Law360
10x, Bruker End Patent Suit on NanoString Gene-Mapping Tools (1) - Bloomberg Law News
Bruker Corporation (BRKR) Declined Amid NIH Funding and Tariff Uncertainty - Yahoo Finance
International Markets and Bruker (BRKR): A Deep Dive for Investors - Yahoo Finance
Repligen, Bruker, Agilent, Medpace, and Revvity Shares Skyrocket, What You Need To Know - Yahoo Finance
Bruker Corporation (BRKR): Among Michael Burry Stocks with Huge Upside Potential - Insider Monkey
Bruker Corporation (BRKR): A Bull Case Theory - MSN
Bruker Corporation (NASDAQ:BRKR) Q1 2025 Earnings Call Transcript - Insider Monkey
Stifel cuts Bruker stock price target to $48, maintains hold By Investing.com - Investing.com Canada
Bruker (BRKR) Sees Price Target Lowered to $45 by UBS | BRKR Sto - GuruFocus
Bruker (BRKR) Sees Price Target Lowered to $45 by UBS | BRKR Stock News - GuruFocus
Bruker (BRKR): Barclays Maintains Rating but Lowers Price Target | BRKR Stock News - GuruFocus
Bruker (BRKR) Target Price Lowered by Goldman Sachs | BRKR Stock News - GuruFocus
Stifel cuts Bruker stock price target to $48, maintains hold - Investing.com
Bruker (BRKR) Stock Target Price Lowered by Stifel Analyst | BRK - GuruFocus
UBS Reduces Price Target for Bruker (BRKR) Amid Funding and Tariff Concerns | BRKR Stock News - GuruFocus
Bruker (BRKR) Stock Target Price Lowered by Stifel Analyst | BRKR Stock News - GuruFocus
Bruker (BRKR) Price Target Reduced by Stifel Amid Flat Growth Outlook | BRKR Stock News - GuruFocus
Bruker Corp Stock (BRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.36%
1.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):